Genome-wide studies have not identified highly consistent, driver somatic variants at other loci in neurofibroma SCs, except where the somatic pathogenic variant is a deletion spanning NF1 and surrounding genes [16–18]. This evidence concerns the gene NF1 and neurofibroma.